PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed dipeptidyl peptidase 1 (DPP1) inhibitor and the first therapy for non-cystic ...

As cyber attacks on major retailers like Pandora continue to hit headlines, experts are urging ecommerce businesses to step ...

The breach was one of the largest reported cyberattack in insurance, as Allianz Life has around 1.4 million customers in the ...

Novartis' mAb ianalumab helped maintain safe platelet levels for a prolonged period, reducing patient reliance on hospital ...

Survey suggests power infrastructure is the biggest barrier to investing in battery-electric vehicles (BEVs) in mining.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

The FTSE 100 and European stocks were mixed on Tuesday as the US and China extended their truce on trade tariffs for another ...

Our editorial team dives into the pharma industry's reaction to US tariffs on imports from the European Union and major ...

"Third time lucky as PharmaTher gets FDA approval for ketamine" was originally created and published by Pharmaceutical ...

The government has announced feed-in tariffs, its revised Power Development Plan 8 (PDP 8) and other policies.